strategic partnerships

BlackBerry's QNX OS powers 275M vehicles as software transition accelerates, backed by $950M backlog and NVIDIA partnership, though insider selling and short interest present risks.

Brookfield Infrastructure reports 10% earnings growth in Q1 2026, driven by AI infrastructure investments and strategic partnerships. Company maintains 4.9% dividend yield.

Capgemini reported 11% Q1 revenue growth to €5,943M, with generative AI bookings exceeding 11% of total wins and 1.02 book-to-bill ratio, signaling strong enterprise AI demand.

Nvidia launches advanced multimodal AI model with 9x higher throughput than competitors. Stock flat as executives plan chipmaker partnerships.

Google secures exclusive geothermal access through Fervo Energy deal with competitor-blocking clauses and right of first refusal, creating 3-gigawatt competitive advantage.

Private LTE market projected to grow 61% to $10.95B by 2030, driven by enterprise security demands and industrial automation, with 12.7% CAGR.

Nebius stock surged 13.8% in March following Nvidia's $2 billion investment, Meta's $27 billion AI infrastructure deals, and $4 billion in convertible notes for expansion.

AAVantgarde Bio names Philip Lao as SVP of Business Development. Lao previously led Adverum's sale to Eli Lilly, bringing pharma expertise from Novartis, Pfizer, and Takeda.

GAM Investments reduced 2025 losses to CHF 74.2M from CHF 77.2M prior year, though AUM declined to CHF 12.5B. New partnerships and restructuring underway.

GAM reported CHF 74.2M net loss in FY2025, improved from prior year, but assets fell to CHF 12.5B amid CHF 3.7B outflows.

TEN Holdings reported $3.1M revenues (down 11.4%) and $19.5M net loss in its first year as public company, offset by doubled customer acquisitions and strategic partnerships.

Nvidia posts $216B revenue with 65% growth amid AI boom, but stock trades at cheapest valuation since ChatGPT, as diversification into PCs, analytics, and edge computing proceeds.

Wolters Kluwer reports €6.1B revenue, accelerates AI strategy through FAB platform, and outlines strategic priorities under CEO Caywood's leadership.

Global respiratory testing market projected to reach $9.32B by 2032, growing 6.50% annually from $5.99B in 2025, driven by molecular diagnostics and telemedicine innovations.

Global cytokines market projected to grow from $95.32B (2025) to $174.53B (2032) at 9.02% CAGR, driven by manufacturing advances and strategic partnerships.

AMD launches industry-first Ryzen AI 400 Series desktop processors for Copilot+ PCs, hitting top 10% momentum while stock remains down year-to-date.

Meta commits to purchasing 6 gigawatts of AMD GPUs and receives warrants for 160 million AMD shares as part of AI infrastructure diversification strategy.

Nvidia shares fell 8.5% despite record earnings. Netflix, AMD, Palantir, and Salesforce also drove market attention with mixed signals on AI and growth momentum.

Companies are transitioning from strategy to execution, with Kraig Biocraft starting spider silk production, Rackspace and Palantir partnering on AI deployment, and Ensysce reviewing strategic options.

Intel stock rose 6.19% on strengthening AI chip demand. The company invested $350M in AI startup SambaNova and partnered strategically to capture growing inference market opportunities.